18.10.2012 • NewsPPG IndustriesPPGQ3 2012

Cost Cuts Help PPG Industries Q3 Profits

Chemicals producer PPG Industries posted a better-than-expected quarterly profit on Thursday as cost cuts helped offset nearly flat revenue.

For the third quarter, net income rose to $339 million, or $2.18 per share, from $311 million, or $1.96 per share, in the year-ago period.

Excluding one-time items, the company earned $2.24 per share. By that measure, analysts expected $2.20, according to Thomson Reuters I/B/E/S.

Net sales slipped less than 1% to $3.85 billion. Analysts expected $3.91 billion.

Pittsburgh-based PPG cut its cost of sales 3% to $2.3 billion.

"Looking to the fourth quarter, we are heading into a seasonally slower period in most end-use markets and expect little change in the inconsistent performance of economies outside North America," Chief Executive Charles Bunch said in a statement.

During the quarter, PPG Industries sold its commodity chemicals business to Georgia Gulf for $2.1 billion in a complex transaction. PPG Industries shareholders receive 50.5% of the shares of a new company to be formed, and Georgia Gulf shareholders get the rest.

The sale gives PPG Industries the cash to bolster its performance coatings and industrial coatings businesses, which make up more than one-half of sales.

PPG Industries also makes the popular Transitions line of eyeglasses.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.